Okay Win, it's March 16, 2013, merger didn't pass...now what? We fundamentally lack marketing and manufacturing and let's say Simes picks up his boot straps and starts tackling these two area's to get Libi to market without FDA approval- we're talking years not months to establish Libi presence to market as we would be essentially starting from zero- how are we going to fund this type of undertaking- I can tell you it'll cost a ton more than 18million...maybe merging with another company or outsourcing/licensing- we had several suitors and according to Simes, this was the best deal- how well will we do with our negotiations with company xyz in the future?
I'm a realist- I got into this company with the belief that Testosterone therapy is big business and the product and the science behind it is strong- A journey of a thousand steps will always start with one etc etc...I'm long and I get we're all underwater, some worse than others, I also understand that ANI and BPAX are a good fit, no one is arguing that; the problem is, no one is mentioning what we can do without a merger/buyout- essentially going it alone for the next year. I wholeheartedly believe that we will be sold for pennies on the dollar should we go it alone, if not go bankrupt in the process.
We have R&D of a few products, some licenses and patents, all of which are no where near full manufacture/marketing potential, we're listed on nasdaq and have 18mil...The question becomes what can BPAX do with all of this vs what can ANI do with it. I chose ANI- getting Simes out the door per merger details makes me think BPAX BOD chose ANI as well.
RG
